Serum Institute of India

FPJ Explains: What is intranasal vaccine, being developed by Serum Institute, Bharat Biotech for COVID-19?

FPJ Explains: What is intranasal vaccine, being developed by Serum Institute, Bharat Biotech for COVID-19?

As COVID-19 cases continue to rise in India, Union Health Minister Dr Harsh Vardhan on Sunday noted that while there were no intranasal v...Read More

Serum Institute to produce additional 100 million COVID-19 vaccine doses

Serum Institute to produce additional 100 million COVID-19 vaccine doses

The Serum Institute of India (SII) on Tuesday said that it will produce additional 100 million COVID-19 vaccine doses for India and low a...Read More

Does Centre have Rs 80,000 crore for COVID vaccine: Adar Poonawalla

Does Centre have Rs 80,000 crore for COVID vaccine: Adar Poonawalla

Mumbai At a time when the debate is underway on the timing of launch of Covid-19 vaccines, Adar Poonawalla, CEO of Serum Institute of Ind...Read More

'Will Centre have Rs 80,000 cr next year?': Serum Institute's Adar Poonawalla on next challenge in COVID-19 fight

'Will Centre have Rs 80,000 cr next year?': Serum Institute's Adar Poonawalla on next challenge in COVID-19 fight

Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said the government needs to have Rs 80,000 crore available over the next ...Read More

COVID-19 vaccine update: Serum Institute to start final phase of trial from next week

COVID-19 vaccine update: Serum Institute to start final phase of trial from next week

The Serum Institute of India (SII) is all set to begin phase three trials of the of University of Oxford and AstraZeneca Plc.’s experimen...Read More

COVID-19 vaccine update: Serum Institute CEO Adar Poonawalla warns of shortage of the COVID-19 vaccine for all till 2024

COVID-19 vaccine update: Serum Institute CEO Adar Poonawalla warns of shortage of the COVID-19 vaccine for all till 2024

The CEO of the Serum Institute of India (SII) Adar Poonawalla has warned of shortage of the COVID-19 vaccine for all till 2024.In an inte...Read More

COVID-19 vaccine update: Serum Institute to resume coronavirus vaccine trials in India after DCGI nod

COVID-19 vaccine update: Serum Institute to resume coronavirus vaccine trials in India after DCGI nod

After clinical trials for AstraZeneca and Oxford University coronavirus vaccine resumed on Saturday in the UK, the Serum Institute of Ind...Read More

Serum Institute of India pauses COVID-19 vaccine trials after DCGI notice

Serum Institute of India pauses COVID-19 vaccine trials after DCGI notice

The Serum Institute of India has paused trials till further instructions from the DCGI after getting a show-cause notice.The phase 2/3 CO...Read More

Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca

Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca

The central drug regulator has issued a show-cause notice to Serum Institute of India (SII) for not informing it about pharma giant Astra...Read More

Adar Poonawalla breaks silence on SII -Covishield clinical trials; says 'stay patient for two months'

Adar Poonawalla breaks silence on SII -Covishield clinical trials; says 'stay patient for two months'

On Thursday, Serum Institute of India CEO Adar Poonawalla asked the media to refrain from reporting on data coming in about patients on S...Read More

Phase II human trial of Oxford vaccine begins in Pune

Phase II human trial of Oxford vaccine begins in Pune

The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at...Read More

COVID-19 vaccine to launch in 10 weeks? Here's what Serum Institute of India has to say

COVID-19 vaccine to launch in 10 weeks? Here's what Serum Institute of India has to say

After several reports around the manufacturing of COVID-19 vaccine, Serum Institute of India, which has partnered with Oxford University ...Read More

Latest update on COVID-19 vaccine: Pune's Serum Institute initiates phase 2, 3 clinical study

Latest update on COVID-19 vaccine: Pune's Serum Institute initiates phase 2, 3 clinical study

Indian pharmaceutical giant Serum Institute of India has initiated the phase 2, 3 clinical trials to evaluate the safety and immune respo...Read More

'Pearl & pride of Pune': Twitter lauds Serum Institute for partnering with Bill Gates Foundation, Gavi for COVID-19 vaccine

'Pearl & pride of Pune': Twitter lauds Serum Institute for partnering with Bill Gates Foundation, Gavi for COVID-19 vaccine

Serum Institute of India (SII) on Friday said it has entered into a new partnership with international vaccine alliance Gavi and Bill &a...Read More

Serum Institute to produce up to 100 mn COVID-19 vaccine doses for India, other countries

Serum Institute to produce up to 100 mn COVID-19 vaccine doses for India, other countries

New Delhi: Serum Institute of India (SII) on Friday said it has entered into a new partnership with international vaccine alliance Gavi a...Read More

Pune's Serum Institute seeks DCGI nod for next phase of clinical trial for Oxford COVID-19 vaccine

Pune's Serum Institute seeks DCGI nod for next phase of clinical trial for Oxford COVID-19 vaccine

Serum Institute of India (SII), which has partnered with AstraZeneca for manufacturing the Oxford vaccine candidate for COVID-19, has sou...Read More

Developed in UK, made in India: What you need to know about Oxford COVID-19 vaccine

Developed in UK, made in India: What you need to know about Oxford COVID-19 vaccine

On Monday, the world was buzzing with hope after scientists at the University of Oxford announced that a vaccine that has been developed ...Read More

Latest Coronavirus Vaccine Update: Serum Institute of India expects COVID-19 vaccine by year-end

Latest Coronavirus Vaccine Update: Serum Institute of India expects COVID-19 vaccine by year-end

Vaccine maker Serum Institute of India (SII) is hoping to develop a COVID-19 vaccine by the year-end as it is focusing on a "good and saf...Read More

COVID-19 Vaccine Latest News: Expert says chances of virus beating vaccine is high

COVID-19 Vaccine Latest News: Expert says chances of virus beating vaccine is high

Ever since the World Health Organisation declared the novel coronavirus, COVID-19, a pandemic, the race is on to develop the first vaccin...Read More

Adar Poonawalla, CEO, Serum Institute of India: Need to examine potential of vaccines to address health issues

Adar Poonawalla, CEO, Serum Institute of India: Need to examine potential of vaccines to address health issues

The Serum Institute of India, part of the Cyrus Poonawalla group, is a key global player in the vaccine space. From being seen as a mass ...Read More

Free Press Journal

www.freepressjournal.in